“Equity and Efficiency in Health and Healthcare”

Mark B. McClellan

Opening Plenary: "Reforming Health Care Delivery"

Bio: Mark B. McClellan, M.D., Ph.D., M.P.A., is senior fellow and director of the Engelberg Center for Healthcare Reform, and Leonard D. Schaeffer Director's Chair in Health Policy Studies at the Brookings Institution.

A former administrator for the Centers for Medicare and Medicaid Services (CMS) and former commissioner of the Food and Drug Administration (FDA), McClellan is currently the director of the Engelberg Center for Health Care reform at the Brookings Institution. The Center is studying ways to provide practical solutions for access, quality, and financing challenges facing the U. S. health care system.

A doctor and economist by training, he is developing and implementing ideas to drive improvements in high-quality, innovative, affordable health care. While at the FDA and CMS, McClellan developed and implemented major reforms in health policy, including the Medicare prescription drug benefit, the FDA's Critical Path Initiative, and public-private initiatives to develop better information on the quality and cost of care.

McClellan's professional experience includes: associate professor of economics and of medicine, Stanford University, 1995-present; administrator, Centers for Medicare and Medicaid Services, 2004-2006; commissioner of Food and Drugs, 2002-2004; member, President's Council of Economic Advisers and senior director for Health Care, White House, 2001-2002; member, Institute of Medicine, 2003-present; research associate, National Bureau of Economic Research, 1995-2001, 2006-present; national fellow, Hoover Institution, Stanford University, 2000-2001; director, Program on Health Outcomes Research, Center for Health Policy and Center for Primary Care and Outcomes Research, Stanford University, 1999-2001; associate editor, Journal of Health Economics, 1998-2001; and deputy assistant secretary for Economic Policy, U.S. Department of the Treasury, 1998-1999. McClellan holds a Ph.D. in economics from the Massachusetts Institute of Technology, an M.D. from Harvard University-Massachusetts Institute of Technology Division of Health Sciences and Technology, an M.P.A. from Harvard University and a B.A. from the University of Texas at Austin.